Roger H. Wilson

Stevenage, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Factors Associated with Time to Sarcoma Diagnosis: Results from a Global Cross-Sectional Survey by the Sarcoma Patient Advocacy Global Network (SPAGN).

Factors Associated with Time to Sarcoma Diagnosis: Results from a Global Cross-Sectional Survey by the Sarcoma Patient Advocacy Global Network (SPAGN).

Journal: Cancers

Published: February 25, 2026

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 23, 2026

Optimising patient centred drug development to realise impact.

Optimising patient centred drug development to realise impact.

Journal: Communications medicine

Published: January 06, 2026

A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR).

A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR).

Journal: The Lancet. Oncology

Published: October 26, 2025

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

Journal: Annals of surgical oncology

Published: August 01, 2025

Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care.

Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care.

Journal: BMJ oncology

Published: May 28, 2025

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 26, 2024

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable.

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable.

Journal: EClinicalMedicine

Published: June 27, 2024

Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.

Recommendations to promote equity, diversity and inclusion in decentralized clinical trials.

Journal: Nature medicine

Published: May 23, 2024

What Is a Sarcoma 'Specialist Center'? Multidisciplinary Research Finds an Answer.

What Is a Sarcoma 'Specialist Center'? Multidisciplinary Research Finds an Answer.

Journal: Cancers

Published: April 10, 2024

Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.

Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.

Journal: Critical reviews in oncology/hematology

Published: January 05, 2024

How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma.

How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 07, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026